This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European prosthetic vascular grafts market. Major topics covered by this report include an overview of selected cardiovascular diseases and disorders (e.g., aneurysm, coronary heart disease, diabetes, hypertension, and stroke); cardiovascular disease management options; and a discussion of products, competitors, and forecast markets for prosthetic vascular graft segments including endovascular stent-grafts for aortic aneurysm repair, hemodialysis access grafts, peripheral vascular grafts, and small-diameter CABG grafts.
EXECUTIVE SUMMARY i. Prosthetic Vascular Grafts a. Applications b. Product Categories c. Hemodialysis Access Grafts d. Endovascular Stent-Grafts for Aortic Aneurysm Repair e. Peripheral Vascular Grafts f. Small-Diameter Coronary Artery Bypass Grafts g. Combined Market Analysis Exhibit ES-1: Europe, Hemodialysis Access Grafts, Market Forecast, by Country, 2012-2017 Exhibit ES-2: Europe, Endovascular Stent-Grafts for Abdominal and Thoracic Aortic Aneurysm Repair, Market Forecast, by Country, 2012-2017 Exhibit ES-3: Europe, Peripheral Vascular Grafts, Market Forecast, by Country, 2012-2017 Exhibit ES-4: Europe, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, by Country, 2012-2017 Exhibit ES-5: Europe, Prosthetic Vascular Grafts, Combined Market Forecast, by Country, 2012-2017 1. OVERVIEW OF SELECTED CARDIOVASCULAR DISEASES/DISORDERS 1.1 Cardiovascular Diseases/Disorders 1.1.1 Coronary Heart Disease 18.104.22.168 Atherosclerosis 22.214.171.124.1 Description 126.96.36.199.2 Statistics 188.8.131.52 Angina Pectoris 184.108.40.206.1 Description 220.127.116.11.2 Statistics 18.104.22.168 Myocardial Infarction 22.214.171.124.1 Description 126.96.36.199.2 Statistics 1.1.2 Hypertension 188.8.131.52 Description 184.108.40.206 Statistics 1.1.3 Aneurysm 220.127.116.11 Description 18.104.22.168 Statistics 1.1.4 Stroke 22.214.171.124 Description 126.96.36.199 Statistics 1.1.5 Diabetes 188.8.131.52 Description 184.108.40.206 Statistics 1.2 Cardiovascular Disease Management Options 1.2.1 Medical Management 220.127.116.11 Lifestyle Changes 18.104.22.168.1 Dietary Modification 22.214.171.124.2 Smoking Cessation 126.96.36.199 Pharmaceuticals 188.8.131.52.1 Anticoagulants and Antiplatelet Drugs 184.108.40.206.2 Lipid-Lowering Drugs 220.127.116.11.3 Antihypertensive Drugs 18.104.22.168.4 Nitroglycerin Preparations 1.2.2 Intracoronary Heart Disease Diagnosis 22.214.171.124 Coronary Angiography 126.96.36.199.1 Description 188.8.131.52.2 Statistics 1.2.3 Coronary Artery Disease Treatment 184.108.40.206 Coronary Artery Bypass Graft Surgery 220.127.116.11.1 Less Invasive Coronary Artery Bypass Graft Techniques 18.104.22.168 Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting 22.214.171.124 Peripheral Percutaneous Revascularization Techniques 126.96.36.199.1 Percutaneous Transluminal Angioplasty and Peripheral Stenting 188.8.131.52.2 Peripheral Atherectomy 184.108.40.206.3 Peripheral Femoropopliteal Stenting Exhibit 1-1: Number of Deaths due to Cardiovascular Diseases/Disorders, by Gender Exhibit 1-2: 2008, Prevalence of Hypercholesterolemia, by Gender Exhibit 1-3: Standard Angina Pectoris Classification Exhibit 1-4: 30-Day Case Fatality Rates Following Hospital Admission for Acute Myocardial Infarction, Selected European Countries Exhibit 1-5: 2008, Prevalence of Hypertension, by Gender Exhibit 1-6: Stroke, Hospital Discharge Rates, 2000 and 2009 Exhibit 1-7: 2008, Prevalence of Elevated Blood Glucose, by Gender Exhibit 1-8: 2007, Daily Per-Person Consumption of Fats, Fruits, and Vegetables Exhibit 1-9: Tobacco Smoking Rate, by Gender Exhibit 1-10: 2006/2007, Medication at Discharge for Patients with Coronary Heart Disease, Selected European Countries Exhibit 1-11: 2007, Cardiac Catheterization Laboratories and Coronary Angiography Procedures, Selected European Countries Exhibit 1-12: 2010, Coronary Artery Bypass Graft Surgery, Selected European Countries, by Type Exhibit 1-13: 2010, Percutaneous Coronary Intervention/Stenting Procedures, Selected European Countries, by Type Exhibit 1-14: 2010, Peripheral Vascular Disease Treatment Procedures, Selected European Countries, by Type 2. THE EUROPEAN PROSTHETIC VASCULAR GRAFTS MARKET 2.1 Prosthetic Vascular Grafting Applications 2.1.1 Aneurysm 2.1.2 Kidney Failure 2.1.3 Vascular Occlusion 2.2 Prosthetic Vascular Graft Categorization 2.2.1 Categorization by Graft Diameter 220.127.116.11 Large-Diameter Grafts 18.104.22.168 Medium-Diameter Grafts 22.214.171.124 Small-Diameter Grafts 2.2.2 Categorization by Graft Material 126.96.36.199 Polyester 188.8.131.52 Polytetrafluoroethylene 184.108.40.206 Polyurethane 220.127.116.11 Biological 18.104.22.168.1 Human Saphenous and Umbilical Veins 22.214.171.124.2 Tissue-Engineered Materials 2.2.3 Endovascular Stent-Grafts 126.96.36.199 Performance Requirements 188.8.131.52 Configurations 184.108.40.206 Endovascular Stent-Graft-Related Complications 2.3 Prosthetic Vascular Grafts Market 2.3.1 Market Drivers and Limiters 2.3.2 Hemodialysis Access Grafts 220.127.116.11 Market Forecast 18.104.22.168 Competitive Analysis 2.3.3 Endovascular Stent-Graft Systems for Aortic Aneurysm Repair 22.214.171.124 Market Forecast 126.96.36.199 Competitive Analysis 2.3.4 Peripheral Vascular Grafts 188.8.131.52 Market Forecast 184.108.40.206 Competitive Analysis 2.3.5 Small-Diameter Coronary Artery Bypass Grafts 220.127.116.11 Market Forecast 18.104.22.168 Competitive Analysis 2.3.6 Combined Market Forecast Exhibit 2-1: Indications for the Use of Prosthetic Vascular Grafts Exhibit 2-2: Interventions for the Treatment of Peripheral Vascular Occlusions Exhibit 2-3: Design Criteria for Synthetic Vascular Grafts Exhibit 2-4: Applications for Prosthetic Vascular Grafts, by Diameter Exhibit 2-5: 2013, Selected Polyester Vascular Grafts Exhibit 2-6: 2013, Selected Polytetrafluoroethylene Vascular Grafts Exhibit 2-7: 2013, Selected Polyurethane Vascular Grafts Exhibit 2-8: Design Specifications for Endovascular Stent-Graft Systems Exhibit 2-9: Complications Associated with the Use of Endovascular Stent-Grafts for Abdominal Aortic Aneurysm Repair Exhibit 2-10: 2013, Selected Endovascular Stent-Grafts for Aortic Aneurysm Repair Exhibit 2-11: Europe, Hemodialysis Access Grafts, Market Forecast, by Country, 2012-2017 Exhibit 2-12: 2012, Europe, Hemodialysis Access Grafts Market, Share by Supplier Exhibit 2-13: Europe, Endovascular Stent-Grafts for Abdominal and Thoracic Aortic Aneurysm Repair, Market Forecast, by Country, 2012-2017 Exhibit 2-14: 2012, Europe, Endovascular Abdominal Aortic Aneurysm Stent-Grafts Market, Share by Supplier Exhibit 2-15: 2012, Europe, Endovascular Thoracic Aortic Aneurysm Stent-Grafts Market, Share by Supplier Exhibit 2-16: Europe, Peripheral Vascular Grafts, Market Forecast, by Country, 2012-2017 Exhibit 2-17: 2012, Europe, Peripheral Vascular Grafts Market, Share by Supplier Exhibit 2-18: Europe, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, by Country, 2012-2017 Exhibit 2-19: 2012, Europe, Small-Diameter Coronary Artery Bypass Grafts Market, Share by Supplier Exhibit 2-20: Europe, Prosthetic Vascular Grafts, Combined Market Forecast, by Country, 2012-2017 3. COMPANY PROFILES 3.1 Atrium Medical Corporation/Getinge Group AB 3.2 C.R. Bard, Inc. 3.3 Cook Group, Inc. 3.4 W.L. Gore & Associates, Inc. 3.5 Maquet Vascular Interventions/Getinge Group AB 3.6 Medtronic, Inc. 3.7 Vascutek LTD/Terumo Corporation APPENDIX: COMPANY LISTING